Patents Assigned to Northern Therapeutics, Inc.
  • Cell-based therapy for the pulmonary system
    Patent number: 11654162
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Grant
    Filed: September 21, 2020
    Date of Patent: May 23, 2023
    Assignee: NORTHERN THERAPEUTICS, INC.
    Inventor: Duncan John Stewart
  • CELL-BASED THERAPY FOR THE PULMONARY SYSTEM
    Publication number: 20210145894
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Application
    Filed: September 21, 2020
    Publication date: May 20, 2021
    Applicant: NORTHERN THERAPEUTICS, INC.
    Inventor: DUNCAN JOHN STEWART
  • Cell-based therapy for the pulmonary system
    Patent number: 10828336
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: November 10, 2020
    Assignee: Northern Therapeutics Inc.
    Inventor: Duncan John Stewart
  • Cell-based therapy for the pulmonary system
    Patent number: 10660922
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: May 26, 2020
    Assignee: Northern Therapeutics Inc.
    Inventor: Duncan John Stewart
  • CELL-BASED THERAPY FOR THE PULMONARY SYSTEM
    Publication number: 20180333438
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Application
    Filed: November 8, 2017
    Publication date: November 22, 2018
    Applicant: Northern Therapeutics Inc.
    Inventor: Duncan John Stewart
  • Cell-based therapy for the pulmonary system
    Patent number: 9827270
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: November 28, 2017
    Assignee: Northern Therapeutics, Inc.
    Inventor: Duncan John Stewart
  • CELL-BASED THERAPY FOR THE PULMONARY SYSTEM
    Publication number: 20170312317
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Application
    Filed: February 27, 2017
    Publication date: November 2, 2017
    Applicant: Northern Therapeutics Inc.
    Inventor: Duncan John Stewart
  • Cell based therapy for the pulmonary system
    Patent number: 9585916
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Grant
    Filed: April 3, 2007
    Date of Patent: March 7, 2017
    Assignee: Northern Therapeutics Inc.
    Inventor: Duncan John Stewart
  • CELL-BASED THERAPY FOR THE PULMONARY SYSTEM
    Publication number: 20140348806
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Application
    Filed: June 13, 2014
    Publication date: November 27, 2014
    Applicant: Northern Therapeutics, Inc.
    Inventor: Duncan John Stewart
  • CELL-BASED THERAPY FOR THE PULMONARY SYSTEM
    Publication number: 20140328810
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Application
    Filed: September 18, 2013
    Publication date: November 6, 2014
    Applicant: Northern Therapeutics, Inc.
    Inventor: Duncan John Stewart